3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Active not recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
3
CNS
3
Genitourinary
2
Gastrointestinal
2
Other solid neoplasm
1
Myeloid
1
Lymphoid
1
Dermatologic
1
Conditions
Myelodysplastic Syndromes
33
Leukemia, Myeloid, Acute
25
Precursor Cell Lymphoblastic Leukemia-Lymphoma
24
Hodgkin Disease
19
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
17
Lymphoma, Non-Hodgkin
16
Myeloproliferative Disorders
15
Leukemia, Lymphocytic, Chronic, B-Cell
15
Multiple Myeloma
14
Graft vs Host Disease
14
Leukemia
13
Primary Myelofibrosis
11
Lymphoma, Mantle-Cell
11
Lymphoma, Large B-Cell, Diffuse
10
Lymphoma, Follicular
10
Leukemia, Myelomonocytic, Chronic
10
Leukemia, Myeloid, Accelerated Phase
10
Lymphoma, B-Cell, Marginal Zone
9
Lymphoma
9
Leukemia, Myeloid, Chronic-Phase
9
Burkitt Lymphoma
9
Blast Crisis
9
Waldenstrom Macroglobulinemia
7
Myelodysplastic-Myeloproliferative Diseases
7
Lymphoma, Large-Cell, Immunoblastic
7
Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative
7
Neoplasms, Plasma Cell
6
Lymphoma, T-Cell, Cutaneous
6
Lymphoma, Large-Cell, Anaplastic
6
Leukemia, Prolymphocytic
6
Interventions
X-Rays
6
Phantoms, Imaging
6
Magnetic Resonance Spectroscopy
6
Specimen Handling
5
Nuclear Medicine Department, Hospital
5
Biopsy
4
ulixertinib
2
tipifarnib
2
tazemetostat
2
selpercatinib
2
palbociclib
2
olaparib
2
larotrectinib
2
ivosidenib
2
erdafitinib
2
ensartinib
2
Vemurafenib
2
LY3023414
2
etoposide phosphate
1
Sirolimus
1
Pharmacogenomic Variants
1
Etoposide
1
Cyclophosphamide
1
Celecoxib
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Rhabdoid Tumor
×
Sirolimus
×
Myeloid
×
Clear all
NCT02574728
2026-03-02
AflacST1502
Emory University
Phase 2
Active not recruiting
46 enrolled